| Comprehensive Health Care | |
|
420 W Longest St Paoli IN 47454-8821 | |
| (812) 723-3944 | |
| (812) 723-5292 |
| Full Name | Comprehensive Health Care |
|---|---|
| Speciality | Clinic/Center |
| Location | 420 W Longest St, Paoli, Indiana |
| Authorized Official Name and Position | Nancy Radcliff (CEO) |
| Authorized Official Contact | 8127237118 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Comprehensive Health Care Po Box 270 Paoli IN 47454-0270 Ph: (812) 723-7118 | Comprehensive Health Care 420 W Longest St Paoli IN 47454-8821 Ph: (812) 723-3944 |
| NPI Number | 1386151371 |
|---|---|
| Provider Enumeration Date | 12/29/2017 |
| Last Update Date | 02/03/2023 |
| Medicare PECOS PAC ID | 5799694360 |
|---|---|
| Medicare Enrollment ID | O20180309002045 |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, working in collaboration with researchers from the Harvard Medical School, today announced that the Journal of Clinical Oncology has published a paper showing the frequency of germline mutations in 25 cancer susceptibility genes among patients with breast cancer.
A study involving more than 200,000 people worldwide has identified 29 DNA sequence variations in locations across the human genome that influence blood pressure.
Bulges in body's major blood vessel can cause potentially lethal ruptures, blood clots. An abdominal aortic aneurysm is a potentially life-threatening condition: If the body's major blood vessel ruptures, it can prove deadly.
Dynavax Technologies Corporation (Nasdaq:DVAX) today announced the initiation of a Phase 3 registration trial for HEPLISAVTM hepatitis B vaccine in individuals with chronic kidney disease. A second registration trial, a Phase 3 lot-to-lot consistency trial, is expected to begin in early 2010. HEPLISAV is an investigational adult hepatitis B vaccine designed to provide increased, rapid protection with fewer doses than current licensed vaccines.
Scientists Dr. Cristina Puig-Saus and Dr. Daniel Shin from the UCLA Jonsson Comprehensive Cancer Center have received a $1 million Translational Research Award from the U.S. Department of Defense Melanoma Research Program to help advance the use of chimeric antigen receptor, or CAR, T cell therapy as a treatment for people with acral, mucosal and uveal melanomas.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386151371 | NPI | - | NPPES |
| 200937580A | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (Indiana) | Primary |
News Archive
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, working in collaboration with researchers from the Harvard Medical School, today announced that the Journal of Clinical Oncology has published a paper showing the frequency of germline mutations in 25 cancer susceptibility genes among patients with breast cancer.
A study involving more than 200,000 people worldwide has identified 29 DNA sequence variations in locations across the human genome that influence blood pressure.
Bulges in body's major blood vessel can cause potentially lethal ruptures, blood clots. An abdominal aortic aneurysm is a potentially life-threatening condition: If the body's major blood vessel ruptures, it can prove deadly.
Dynavax Technologies Corporation (Nasdaq:DVAX) today announced the initiation of a Phase 3 registration trial for HEPLISAVTM hepatitis B vaccine in individuals with chronic kidney disease. A second registration trial, a Phase 3 lot-to-lot consistency trial, is expected to begin in early 2010. HEPLISAV is an investigational adult hepatitis B vaccine designed to provide increased, rapid protection with fewer doses than current licensed vaccines.
Scientists Dr. Cristina Puig-Saus and Dr. Daniel Shin from the UCLA Jonsson Comprehensive Cancer Center have received a $1 million Translational Research Award from the U.S. Department of Defense Melanoma Research Program to help advance the use of chimeric antigen receptor, or CAR, T cell therapy as a treatment for people with acral, mucosal and uveal melanomas.
› Verified 6 days ago
Comprehensive Health Care Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 420 W Longest St, Paoli, IN 47454 Phone: 812-723-3944 Fax: 812-723-7991 | |
Comprehensive Health Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 420 W Longest St, Paoli, IN 47454 Phone: 812-723-3944 Fax: 812-723-5292 | |
Iu Health Paoli Family And Internal Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 560 W. Longest Street, Paoli, IN 47454 Phone: 812-723-7440 |